BioNano Genomics, Inc (BNGO) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 74 transactions totaling $395.0K, demonstrating a bullish sentiment with $250.2K in net insider flow. The most recent transaction on Sep 11, 2025 involved a transaction of 51 shares valued at $207.
No significant insider buying has been recorded for BNGO in the recent period.
No significant insider selling has been recorded for BNGO in the recent period.
Based on recent SEC filings, insider sentiment for BNGO is bullish with an Insider Alignment Score of 82/100 and a net flow of $250.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BioNano Genomics, Inc (BNGO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading BNGO stock, having executed 74 transactions in the past 90 days. The most active insider is James C. Blair (Executive), who has made 3 transactions totaling $1.6M.
Get notified when executives and directors at BNGO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Chaubey Alka | Executive | Payment | 51 | $4.06 | $207 | |
| Sep 11, 2025 | Oldakowski Mark | Executive | Payment | 59 | $4.06 | $240 | |
| Sep 11, 2025 | Oldakowski Mark | Executive | Payment | 59 | $4.06 | $240 | |
| Sep 11, 2024 | Chaubey Alka | Executive | Payment | 3,075 | $0.48 | $1.5K | |
| Sep 11, 2024 | Oldakowski Mark | Executive | Payment | 3,568 | $0.48 | $1.7K | |
| Jun 3, 2024 | Chaubey Alka | Executive | Award | 16,000 | $N/A | $0 | |
| Jun 3, 2024 | Dixon Jonathan V | Executive | Award | 14,500 | $N/A | $0 | |
| Jun 3, 2024 | Erik Holmlin R. | Executive | Award | 44,000 | $N/A | $0 | |
| Jun 3, 2024 | Kama Gulsen | Executive | Award | 16,000 | $N/A | $0 | |
| Jun 3, 2024 | Oldakowski Mark | Executive | Award | 16,000 | $N/A | $0 | |
| Feb 15, 2024 | Dixon Jonathan V | Executive | Payment | 402 | $1.27 | $511 | |
| Feb 15, 2024 | Erik Holmlin R. | Executive | Payment | 3,073 | $1.27 | $3.9K | |
| Feb 15, 2024 | Oldakowski Mark | Executive | Payment | 1,229 | $1.27 | $1.6K | |
| Feb 15, 2024 | Chaubey Alka | Executive | Payment | 1,081 | $1.27 | $1.4K | |
| Sep 18, 2023 | Chaubey Alka | Executive | Award | 20,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 23 | $1.6M | 67.1% |
Purchase(P) | 12 | $322.6K | 13.9% |
Payment(F) | 13 | $200.9K | 8.6% |
Exercise(M) | 6 | $98.3K | 4.2% |
Sale(S) | 1 | $72.4K | 3.1% |
Award(A) | 18 | $70.5K | 3.0% |
Gift(G) | 1 | $0 | 0.0% |
Insiders at BioNano Genomics, Inc are accumulating shares at an accelerated pace. With 18 insiders making 74 transactions totaling $322.6K in purchases versus $72.4K in sales, the net buying activity of $250.2K signals strong executive confidence. James C. Blair (Executive) leads the buying activity with $1.6M in transactions across all time.